Albumin
Albumin is a pharmaceutical drug with 55 clinical trials. Currently 3 active trials ongoing. Historical success rate of 87.9%.
Success Metrics
Based on 29 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
11
Mid Stage
20
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.3%
29 of 38 finished
23.7%
9 ended early
3
trials recruiting
55
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
The Intensive Care Platform Trial
Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites
Albumin in Acute Variceal Bleeding
High Dose Albumin in Refractory Ascites
Clinical Trials (55)
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
The Intensive Care Platform Trial
Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites
Albumin in Acute Variceal Bleeding
High Dose Albumin in Refractory Ascites
Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study
Intra-arterial Albumin Infusion After Endovascular Therapy for Stroke Patients
Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).
Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.
Transthoracic Echocardiographic Monitoring of Cardiac Output Effects of Colloid Preload and Crystalloid Coload During Cesarean Delivery Under Spinal Anesthesia
ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED)
Comparison of Safety and Efficacy of Tailored Versus Fixed Dose Albumin for the Management of Patients With Cirrhosis and Sepsis Associated Acute Kidney Injury
IVIG (Gamunex-C) Treatment Study for POTS Subjects
Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.
Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.
Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)
Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis
Effect of Balanced Saline Solution and Albumin on Volume Expansion in Shock Patients
To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI Development
Study on Efficacy and Safety of Human Albumin in Burn Shock Recovery
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 55